Lack of association between NYD-SP18 variant and obesity :  the health alcohol and psychosocial factors in Eastern Europe study by Hubacek, Jaroslav A. et al.
E-Mail karger@karger.com
 Original Paper 
 Ann Nutr Metab 2016;68:244–248 
 DOI: 10.1159/000445982 
 Lack of Association between  NYD-SP18 Variant 
and Obesity. The Health Alcohol and Psychosocial 
Factors in Eastern Europe Study 
 Jaroslav A. Hubacek  a    Hynek Pikhart  c    Ruzena Kubinova  b    Anne Peasey  c    
Sofia Malyutina  d    Andrzej Pajak  e    Abdonas Tamosiunas  f    Martin Bobak  c 
 a   Center for Experimental Medicine, Institute for Clinical and Experimental Medicine,  b   Centre for Health Monitoring, 
National Institute of Public Health,  Prague , Czech Republic;  c   Department of Epidemiology and Public Health, 
University College London,  London , UK;  d   Institute of Internal and Preventive Medicine, Russian Academy of Medical 
Sciences,  Novosibirsk , Russia;  e   Department of Epidemiology and Population Studies, Institute of Public Health, 
Faculty of Health Care, Jagiellonian University Medical College,  Krakow , Poland;  f   Department of Population Studies, 
Institute of Cardiology of Lithuanian University of Health Sciences,  Kaunas , Lithuania
 
association of the  NYD-SP18 genotype with waist-hip ratio. 
 Conclusion: This study in a large Slavonic population sample 
suggests that the rs6971091 variant within the  NYD-SP18 
gene is not an important determinant of obesity in middle-
aged persons. © 2016 The Author(s)
Published by S. Karger AG, Basel 
 Introduction 
 Obesity is a common preventable risk factor of a range 
of chronic conditions, including cardiovascular diseases, 
cancer and diabetes. In some populations, as much as 
60% of individuals are overweight or obese  [1] . Obesity 
or overweight generally results from positive energy bal-
ance caused predominantly by low physical activity and 
high energy intake, although other factors, such as sleep-
ing deficit or social factors also play a role  [2] . In addition 
to these environmental factors, obesity and body mass 
index (BMI) are significantly influenced by genetic fac-
tors. Twin studies suggest that genetic influences may ex-
plain as much as 40–70% of the variation in BMI  [3] . 
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 Abstract 
 Aim: To replicate the finding that the polymorphism 
rs6971091 within the  NYD-SP18 gene is associated with body 
mass index (BMI).  Method: We analysed data of 29,284 adults 
(46.2% of males, mean age 58.9 (SD 7.3), mean BMI 28.6 (5.0 
kg/m 2 )) examined within the Health Alcohol and Psychoso-
cial Factors in Eastern Europe study in the Czech Republic, 
Poland, Lithuania and Russia.  Results: BMI did not differ by 
rs6971091 genotype. In men, the mean BMI (SEs) in GG, GA 
and AA carriers were 27.8 (0.05), 27.9 (0.06) and 27.9 (0.14) 
kg/m 2 , respectively, (p = 0.26); in women, the corresponding 
values were 29.2 (0.06), 29.1 (0.07) and 29.1 (0.16), p = 0.57. 
In Czech subjects (n = 6,752), for whom the  FTO rs17817449 
genotype was available, there was no interaction between 
the  NYD-SP18 and  FTO polymorphisms in determination of 
BMI. Adjustment for age, energy and fat intake and physical 
activity did not materially change the results. There was no 
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However, despite intensive research efforts in the last de-
cades, only a relatively small part of the BMI heritability 
has been attributed to specific genetic factors.
 Among the polymorphisms with known association 
with obesity, the most important are the  FTO 1st intron 
variants  [4] . The study based on the NHLBI Family Heart 
Study and the Framingham study identified a single nu-
cleotide polymorphism (rs697109) within the  NYD-SP18 
gene (gene ID 84691) as associated with obesity  [5] . The 
gene was identified using fine mapping of the region on 
chromosome 7, which has been known for a long time to 
be associated with obesity  [6] . The authors reported an 
effect of the  NYD-SP18 variants on obesity that was even 
larger than the effect of the  FTO polymorphism  [5] . More 
recently, the association between the rs697109 SNP and 
BMI was confirmed in males, but not in females  [7] . In 
addition, the additive effect between this SNP and 1st in-
tron polymorphism of the  FTO gene on BMI values has 
been detected  [7] . Finally, a small intervention study in 
females suggested that  NYD-SP18 polymorphism could 
be a significant predictor of positive body composition 
changes after a short-term intensive life style intervention 
 [8] .
 The  NYD-SP18  gene is known to play a role in the de-
velopment of testicles (Locus ID 84691), but the mecha-
nisms that may link it with obesity development are not 
known. Rs6971091 is a non-synonymous polymorphism 
(G>A; Lys242>Glu), and it was predicted that it could 
cause the misfolding of the native protein (http://snpef-
fect.vib.be/snp_main.php?id=27249604)  [9] .
 To the best of our knowledge, the effect of the rs6971091 
SNP on obesity has not been independently replicated in 
a different population sample. The aim of this study is to 
test the replicability of the previously described associa-
tion between the rs6971091 SNP within the  NYD-SP18 
 gene and obesity-associated traits.
 Subjects and Methods 
 We analysed data from 4 large population-based cohorts of 
adults established as part of the Health Alcohol and Psychosocial 
Factors in Eastern Europe (HAPIEE) study in the Czech Republic, 
Lithuania, Poland and Russia  [10] . The cohorts consist of random 
samples of both men and women aged 45–69 (45–75 in Lithuania) 
at baseline. Subjects were selected from population registers; no 
exclusion criteria have been applied.
 Dietary intakes of energy and macro- and micro-nutrients were 
assessed by 143-items Food Frequency Questionnaire as described 
previously  [11, 12] . Physical activity was assessed by questions ask-
ing how many hours per week the responders engaged in sports, 
games or hiking. The socioeconomic status was characterised by 
participants’ highest achieved education and the economic activi-
ties they were involved in  [10] .
 All subjects provided a written informed consent to participate 
in the study. The study was approved by appropriate institutional 
Ethics Committees in agreement with the Helsinki Declaration of 
1975.
 DNA was extracted from the peripheral blood and  NYD-SP18 
 SNP rs6971091 was genotyped using the KASP TM methodology 
(KBioscience, London, England)  [13] . Genotyping call rate was 
97.98%. Both in the entire study (p = 0.77) and within each of the 
4 populations, there was no evidence of deviation from the Hardy–
Weinberg equilibrium. Means and SEs of BMI and waist-to-hip 
ratio (WHR) were estimated by linear regression post-estimation 
of adjusted means. STATA statistical software (version 12) was 
used for all analyses. Age, energy intake, fat intake, physical activ-
ity, education and socioeconomic status were included in adjusted 
analysis. p values (calculated for trend) <0.05 were considered sig-
nificant.
 Results 
 Descriptive characteristics of study participants are 
shown in  table 1 . There were only minor differences be-
tween countries. For instance, Lithuanians had the high-
est mean age and the highest mean BMI (both p values 
<0.001). The genotype (allele) distributions were similar 
across the countries; the overall allele distribution (with 
minor A allele frequency of 26%) were also similar to the 
distribution reported previously (frequency of the minor 
allele 23%)  [5, 7] . In our study, both overall and within 
each cohort, the rs6971091 polymorphism was not asso-
ciated with BMI values; all p values were >0.45 in codomi-
nant models ( table  1 ). The results remain insignificant 
after adjustment for age and other covariates and in domi-
nant and recessive models. Results of WHR were similar; 
the mean (SEs) of WHR in males with GG, GA and AA 
genotypes were 0.943 (0.001), 0.943 (0.001) and 0.945 
(0.002), respectively, with p = 0.432; in females, the cor-
responding values were 0.834 (0.001), 0.838 (0.001) and 
0.835 (0.002), respectively, with p = 0.814.
 We have not detected any significant interaction be-
tween energy intake and  NYD-SP18 polymorphism in 
predicting BMI, either in the combined male and female 
population or when males and females were analysed sep-
arately. We did not find any associations of this variant 
with total dietary intake of energy or saturated and un-
saturated fats.
 Finally, in the Czech cohort (n = 6,752), where data on 
 FTO rs17817449 genotype were available  [14] , we exam-
ined an interaction between FTO  and NYD-SP18 geno-
types ( table 2 ). While  FTO was strongly associated with 
BMI (as reported earlier  [14] ), there was no suggestion of 
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an association between  FTO and  NYD-SP18 polymor-
phisms (p = 0.323) or of an interaction between these 2 
genotypes in determining BMI (p = 0.664) or WHR (p = 
0.564, not shown in the  table 2 ).
 Discussion 
 Genome-wide association studies and the deep se-
quencing of areas with high logarithm of odds score for 
obesity have detected dozens of SNPs with the potential 
to significantly affect BMI. However, many of the asso-
ciations detected in the primary studies remain uncon-
firmed. It is important that results from even large ge-
netic association studies are replicated in independent 
population samples  [15] ; the reasons include statistical 
issues (to exclude false positive findings), possible inter-
ethnic differences and potential modification of genetic 
effects by environmental and life style factors.
 There is a wide list of genes/variants potentially associ-
ated with BMI or other indicators of obesity; however, 
definitive conclusions are sometimes difficult to be drawn 
Table 1. Basic characteristics of subjects with successful NYD-SP18 genotyping
Country Czech Republic Lithuania Poland Russia Total
Number 6,725 6,828 8,742 6,989 29,284
Males, % 46.0 46.0 49.0 43.1 46.2
Age, years 58.3±7.1 61.0±7.6 57.7±7.0 58.9±7.1 58.9±7.3
BMI, kg/m2 28.2±4.6 29.3±5.3 28.2±4.6 28.6±5.4 28.6±5.0
WHR 0.886±0.085 0.894±0.087 0.880±0.083 0.888±0.087 0.886±0.085
NYD-SP18 rs6971091
GG 3,672 (54.6) 3,697 (54.1) 4,659 (53.3) 3,806 (54.5) 15,834 (54.1)
AG 2,582 (38.5) 2,645 (38.9) 3,482 (39.8) 2,703 (38.7) 11,412 (39.0)
AA 471 (7.0) 486 (7.1) 601 (6.9) 480 (6.9) 2,038 (7.0)
BMI by rs6971091 NYD-SP18 in men
GG 28.2±0.1 28.5±0.1 27.9±0.1 26.6±0.1 27.8±0.05
GA 28.5±0.1 28.5±0.1 28.0±0.1 26.5±0.1 27.9±0.06
AA 28.0±0.3 28.9±0.3 27.9±0.2 27.0±0.3 27.9±0.14
p value 0.59 0.45 0.80 0.46 0.26
BMI by rs6971091 NYD-SP18 in women
GG 28.1±0.1 30.2±0.1 28.4±0.1 30.2±0.1 29.2±0.06
GA 28.2±0.1 29.9±0.1 28.3±0.1 30.1±0.1 29.1±0.07
AA 27.7±0.3 30.1±0.3 28.4±0.3 30.2±0.3 29.1±0.16
p value 0.67 0.49 0.67 0.67 0.57
Genotype frequency is given as n (%), BMI values are reported as mean ± SE. Linear regression.
Table 2. BMI values (mean ± SEs) of by the combination of FTO (rs17817449) and NYD-SP18 (rs6971091) poly-
morphisms in Czech subjects (both genders combined)
NYD-SP18 genotype  FTO genotype p for trend
G G GT TT total
GG 28.6±0.2 28.3±0.1 27.8±0.1 28.2±0.1 <0.001
GA 28.8±0.2 28.3±0.1 28.0±0.2 28.3±0.1 0.002
AA 28.7±0.5 28.0±0.3 27.3±0.3 27.9±0.2 0.016
Total 28.7±0.1 28.3±0.1 27.8±0.1 28.2±0.1 <0.001
p for trend 0.458 0.434 0.851 0.828 0.662*
Mean BMI are reported as mean ± SE. Linear regression.* p for interaction = 0.662.
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 [16–22] . Importantly, not all genetic variants are associ-
ated with BMI under all conditions in all population, as is 
the case of  FTO  [23] . For several genotypes, it has been 
reported that dietary and genetics factors may interact 
with one another (e.g. variants at  MC4r  [24] ,  APOA5  [25] 
or  TFAP2B  [26] ).
 In the case of the promising candidate, SNPs within 
the  NYD-SP18 gene area, the potential physiological link 
between this gene and obesity remain unknown; howev-
er, this applies to some extent to most obesity-associated 
genes (such as  TMEM18  or  FTO ). In the original report 
 [5], it was suggested that  NYD-SP18 polymorphism may 
influence plasma leptin levels.
 The primary report  [5] found the association with obe-
sity in two independent population samples; however, the 
relatively small sample size in these studies (several hun-
dred individuals in each sample) makes them prone to 
false positive results. More recently, the association has 
been detected in males, but not in females, in the Czech 
post-MONICA study  [7] . The possible role of the  NYD-
SP18 in the determination of BMI has been further sug-
gested in a small intervention study  [8] of overweight 
non-diabetic females; the results suggest that common 
homozygotes profit more from the intensive life style in-
tervention than carriers of the minor A allele.
 Our study, with almost 30,000 unrelated adults, was 
much larger. We have found not even a slight suggestion 
of a trend in BMI by  NYD-SP18 . In addition, in a subset 
of 6,500 individuals, we found no evidence of interac-
tions with the  FTO genotype or dietary intakes energy or 
fats.
 There is one major limitation of our study, which can 
potentially explain the difference between the previous 
reports  [5, 7] and our study. Both previous papers  [5, 7] 
also included younger individuals, while the HAPIEE 
study only covers persons aged 45 years or older. We, 
therefore, cannot exclude the possibility that an associa-
tion between the  NYD-SP18  genotype and BMI exists in 
younger age groups. However, given the results of this 
large study, we conclude that the rs6971091 SNP within 
the  NYD-SP18 gene is unlikely to be an important genet-
ic determinant of BMI per se.
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